Mathieu Lapointe

Validation of warfarin pharmacogenetic algorithms

R. Brugada, J. Tardif, J. Turgeon, 2012 .

De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia

Marie-Pierre Dubé, Christian Néri, Marie-Odile Krebs, 2010, Proceedings of the National Academy of Sciences.

Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia

Laurent Mottron, Ann Marie Craig, Marie-Odile Krebs, 2011, Human Genetics.

De Novo Truncating Mutation in Kinesin 17 Associated with Schizophrenia

L. DeLisi, J. Rapoport, E. Fombonne, 2010, Biological Psychiatry.

Validation of warfarin pharmacogenetic algorithms in clinical practice.

R. Brugada, J. Tardif, J. Turgeon, 2012, Pharmacogenomics.